Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy

S. Louhaichi (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), A. Akkad (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), A. Berraies (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)

Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4248
Disease area: Airway diseases, Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Louhaichi (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), A. Akkad (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), A. Berraies (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia). Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy. 4248

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omalizumab: therapeutic approach to asthma and comorbidities
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Adherence to asthma therapy: elaborating a measurement model
Source: Eur Respir J 2001; 18: Suppl. 33, 441s
Year: 2001

The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



An algorithmic approach for the treatment of severe uncontrolled asthma
Source: ERJ Open Res, 4 (1) 00125-2017; 10.1183/23120541.00125-2017
Year: 2018



Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006



Is it really severe asthma? A systematic approach to assessment
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019


A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 666s
Year: 2006

Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005

A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021



Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

Severe asthma: approach to diagnosis and treatment
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



The concept of control in COPD: a new proposal for optimising therapy
Source: Eur Respir J 2014; 44: 1072-1075
Year: 2014


Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002

Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults
Source: Eur Respir Rev 2014; 23: 510-518
Year: 2014



Unbiased approaches to asthma stratification: the road to novel therapies
Source: International Congress 2017 – PG15 Asthma stratification
Year: 2017


A simple score for future risk prediction in patients with controlled asthma who undergo a step-down guidelines-based strategy.
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score.
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012